Scientists at King Abdullah University of Science and Technology (KAUST) have engineered tiny metal-organic frameworks (MOFs) to deliver a team of six proteins into living cells. Inside the cells, these proteins formed a nanoscale factory that successfully produced violacein, a natural bioactive compound with therapeutic potential. This breakthrough represents the most complex multiprotein system delivered into living cells to date and the first example of a 'protein pathway transplant'. Why it matters: This research offers an early demonstration of how future therapies might generate treatment molecules directly inside the body at disease sites, potentially leading to more precise and less toxic medical interventions.
Five students from King Abdullah University of Science and Technology (KAUST) have been selected to participate in the 75th Lindau Nobel Laureate Meeting in Germany, scheduled for June 28 to July 3, 2026. These students, from various fields including electrical and computer engineering, bioengineering, and chemistry, are among only 600 young researchers worldwide chosen for this distinguished intergenerational scientific exchange. KAUST is the sole Saudi institution represented at the prestigious event, which will involve interaction with approximately 75 Nobel Laureates. Why it matters: This selection highlights KAUST's commitment to cultivating exceptional talent and its growing global reputation in science, indicating potential future scientific leadership from the region.
KAUST and University College London (UCL) have formed a strategic partnership to advance research, education, and commercialization. The partnership includes potential collaboration in student entrepreneurship, academic program development such as joint MBA programs, and joint activity in bioengineering fields like vaccine manufacturing. The agreement was signed during the Times Higher Education World Academic Summit 2025 held at KAUST. Why it matters: This collaboration strengthens KAUST's ability to advance Saudi Vision 2030 by expanding its international research network, enabling translational innovation, and accelerating commercialization.
Kyle Lauersen, Assistant Professor of Bioengineering at KAUST, credits his early martial arts training for instilling focus and confidence. He initially pursued education degrees but shifted to molecular biology and genetic engineering after lab experiences. Lauersen's PhD work in Germany involved recoding algal genes for biotechnology. Why it matters: His journey highlights the diverse paths to STEM careers and KAUST's role in attracting international researchers focused on sustainable biotechnology.
Three KAUST researchers, Asma Al-Amoodi, Walaa Khushaim, and Hajar Al-Zarah, have been selected to attend the 72nd Lindau Nobel Laureate Meetings in Germany. They will join 600 young scientists to discuss physiology and medicine with around 40 Nobel Laureates. The students, pursuing PhDs in Biological and Environmental Science and Engineering (BESE), will have networking opportunities through lectures, talks, and discussions. Why it matters: This recognition highlights KAUST's growing prominence in bioscience and bioengineering research and provides a platform for young Saudi researchers to engage with leading global scientists.
Professor Sahika Inal, associate professor of bioengineering at KAUST, has been named a Fellow of the Royal Society of Chemistry (RSC). This recognizes her work in designing electronic devices for efficient communication with biological systems. Inal's work involves organic electronic materials and devices for research, clinical health monitoring, and therapy. Why it matters: This fellowship elevates KAUST's profile in biomedical engineering and highlights the importance of interdisciplinary research in addressing critical healthcare challenges.
KAUST Research Scientist Dr. Ram Karan received a Young Scientist Award at the 15th International Congress on Thermophiles in Japan for his work on extremozymes from Red Sea brine pools. His research focuses on identifying, purifying, and bioengineering microbial proteins from these pools. He utilizes single-amplified genomes (SAGs) to produce extremozyme proteins without needing to grow cells in the lab. Why it matters: This award recognizes KAUST's innovative research into extremophiles, which have the potential to develop novel, sustainable biotechnical processes for industrial applications.
KAUST researchers are working to improve gene editing tools, specifically CRISPR/Cas9, for crop bioengineering to address food security challenges. Magdy Mahfouz's lab is developing a germline engineering platform to produce gene-edited plants without foreign DNA and bypass time-consuming tissue culture. A recent European court decision classifies CRISPR/Cas9 crops as GMOs, facing stringent regulations, contrasting with the U.S. where CRISPR-edited mushrooms are already available. Why it matters: Advances in gene editing at KAUST could significantly enhance crop yields and stress tolerance in the region, but regulatory hurdles remain a key challenge for deployment.